Nuclear physics is an integral part of our everyday lives (Figure 10.7.1). Radioactive compounds are used to identify cancer, study ancient artifacts, and power our cities. Nuclear fusion also powers the Sun, the primary source of energy on Earth. The focus of this chapter is nuclear radiation. In this section, we ask such questions as: How is nuclear radiation used to benefit society? What are its health risks? How much nuclear radiation is the average person exposed to in a lifetime?
Most medical and related applications of nuclear physics are driven, at their core, by the difference between a radioactive substance and a non-radioactive substance. One of the first such methods is the precision measurement and detection method known as radioimmunoassay (RIA). Developed by Rosalyn Sussman Yalow and Solomon Berson in the late 1950s, RIA relies on the principle of competitive binding. For the particular substance being measured, a sample containing a radioactive isotope is prepared. A known quantity of antibodies is then introduced. By measuring the amount of "unbound" antibodies after the reaction, technicians can detect and measure the precise amount of the target substance. Radioimmunoassay is essential in cancer screening, hepatitus diagnosis, narcotics investigation, and other analyses.
One of the most important uses of nuclear radiation is the location and study of diseased tissue. This application requires a special drug called a radiopharmaceutical. A radiopharmaceutical contains an unstable radioactive isotope. When the drug enters the body, it tends to concentrate in inflamed regions of the body. (Recall that the interaction of the drug with the body does not depend on whether a given nucleus is replaced by one of its isotopes, since this interaction is determined by chemical interactions.) Radiation detectors used outside the body use nuclear radiation from the radioisotopes to locate the diseased tissue. Radiopharmaceuticals are called radioactive tags because they allow doctors to track the movement of drugs in the body. Radioactive tags are for many purposes, including the identification of cancer cells in the bones, brain tumors, and Alzheimer’s disease (Figure 10.7.2). Radioactive tags are also used to monitor the function of body organs, such as blood flow, heart muscle activity, and iodine uptake in the thyroid gland.
Table 10.7.1 lists some medical diagnostic uses of radiopharmaceuticals, including isotopes and typical activity (A) levels. One common diagnostic test uses iodine to image the thyroid, since iodine is concentrated in that organ. Another common nuclear diagnostic is the thallium scan for the cardiovascular system, which reveals blockages in the coronary arteries and examines heart activity. The salt TlCl can be used because it acts like NaCl and follows the blood. Note that Table 10.7.1 lists many diagnostic uses for {}^{\text{99m} }\text{Tc}, where “m” stands for a metastable state of the technetium nucleus. This isotope is used in many compounds to image the skeleton, heart, lungs, and kidneys. About 80\text{\%} of all radiopharmaceuticals employ {}^{\text{99m} }\text{Tc} because it produces a single, easily identified, 0.142-MeV \gamma ray and has a short 6.0-h half-life, which reduces radiation exposure.
Table 10.7.1 Diagnostic Uses of Radiopharmaceuticals
Procedure, Isotope Activity (mCi), where 1\,\text{mCi}=3.7\,\times\,{10}^{7}\text{Bq} Procedure, Isotope Activity (mCi), where 1\,\text{mCi}=3.7\,\times\,{10}^{7}\text{Bq}
Brain scan;Thyroid scan
{}^{\text{99m} }\text{Tc};7.5;{}^{131}\text{I};0.05 {}^{15}\text{O} (PET);50;{}^{123}\text{I};0.07Lung scan;Liver scan
{}^{133}\text{Xe};7.5;{}^{198}\text{Au} (colloid);0.1 {}^{\text{99m} }\text{Tc};2;{}^{\text{99m} }\text{Tc} (colloid);2Cardiovascular blood pool;Bone scan
{}^{131}\text{I};0.2;{}^{85}\text{Sr};0.1 {}^{\text{99m} }\text{Tc};2;{}^{\text{99m} }\text{Tc};10Cardiovascular arterial flow;Kidney scan
{}^{201}\text{Tl};3;{}^{197}\text{Hg};0.1 {}^{24}\text{Na};7.5;{}^{\text{99m} }\text{Tc};1.5The first radiation detectors produced two-dimensional images, like a photo taken from a camera. However, a circular array of detectors that can be rotated can be used to produce three-dimensional images. This technique is similar to that used in X-ray computed tomography (CT) scans. One application of this technique is called single-photon-emission CT (SPECT) (Figure 10.7.3). The spatial resolution of this technique is about 1 cm.
Improved image resolution is achieved by a technique known as positron emission tomography (PET). This technique use radioisotopes that decay by {\beta}^{+} radiation. When a positron encounters an electron, these particle annihilate to produce two gamma-ray photons. This reaction is represented by
{e}^{+}+{e}^{-}\to2\gamma.These \gamma-ray photons have identical 0.511-MeV energies and move directly away from one another (Figure 10.7.4). This easily identified decay signature can be used to identify the location of the radioactive isotope. Examples of {\beta}^{+}-emitting isotopes used in PET include {}^{11}\text{C},\,{}^{13}\text{N},\,{}^{15}\text{O},\,\text{and}\,{}^{18}\text{F}. The nuclei have the advantage of being able to function as tags for natural body compounds. Its resolution of 0.5 cm is better than that of SPECT.
PET scans are especially useful to examine the brain’s anatomy and function. For example, PET scans can be used to monitor the brain’s use of oxygen and water, identify regions of decreased metabolism (linked to Alzheimer’s disease), and locate different parts of the brain responsible for sight, speech, and fine motor activity
Register to read the full text
This page shows only part of the content. Register or log in to read it all.
Register / Log in